4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-036268
President, CEO, and Chairman gave up 106,093 shares (to pay taxes)
- President, CEO, and Chairman acquired 572,983 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2026-01-31 | Option exercise | +272,983 | 573,923 | D: show line 1 in the form | ||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2026-01-31 | Shares withheld for taxes | −106,093 | $4.24 | $449,834 | 467,830 | D: show line 2 in the form |
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2026-02-03 | Option exercise | +300,000 | $1.24 | $372,000 | 767,830 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2026-01-31 | Option exercise · Restricted Stock Units | −173,466 | 0 | D: show line 4 in the form | ||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2026-01-31 | Option exercise · Restricted Stock Units | −99,517 | 0 | D: show line 5 in the form | ||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2026-02-03 | Option exercise · Stock Option (Right to Buy) | −300,000 | 0 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…